Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1158-1168

  Ohyama, Bungo ^a,b   Nishifuji, Koji ^b,c   Chan, Po Tak ^b,d   Kawaguchi, Atsushi ^e   Yamashita, Takuto ^e   Ishii, Norito ^a   Hamada, Takahiro ^a   Dainichi, Teruki ^a   Koga, Hiroshi ^a   Tsuruta, Daisuke ^a   Amagai, Masayuki ^b   Hashimoto, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d DEPARTMENT OF HEALTH   (Hong Kong)

^e KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DESMOGLEIN 1; DESMOGLEIN 2; DESMOGLEIN 3; EPITOPE; MONOCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ARTICLE; DISEASE COURSE; EXTRACELLULAR SPACE; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; PEMPHIGUS HERPETIFORMIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 84858295531     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.448     Document Type: Article

References (45)

1. Amagai M (2003) Desmoglein as a target in autoimmunity and infection. J Am Acad Dermatol 48:244-52
2. Amagai M, Hashimoto T, Green KJ et al. (1995) Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 104:895-901
3. Amagai M, Hashimoto T, Shimizu N et al. (1994) Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 94:59-67
4. Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869-77
5. Amagai M, Komai A, Hashimoto T et al. (1999) Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 140:351-7
6. Amagai M, Nishikawa T, Hossein C et al. (1998) Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 102:775-82
7. Chan PT, Ohyama B, Nishifuji K et al. (2010) Immune response towards the amino-terminus of desmoglein 1 prevails across different activity stages in nonendemic pemphigus foliaceus. Br J Dermatol 162:1242-50
8. Chen Y, Langrish CL, McKenzie B et al. (2006) Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116:1317-25
9. Cheng SW, Kobayashi M, Tanikawa A et al. (2002) Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 147:261-5
10. Futei Y, Amagai M, Hashimoto T et al. (2003) Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus. J Am Acad Dermatol 49:1023-8
11. Futei Y, Amagai M, Sekiguchi M et al. (2000) Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J Invest Dermatol 115:829-34
12. Goebels N, Hofstetter H, Schmidt S et al. (2000) Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: Epitope spreading versus clonal persistence. Brain 3:508-18
13. Hashimoto T, Amagai M, Watanabe K et al. (1995) Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 104:829-34
14. Horwitz MS, Bradley LM, Harbertson J et al. (1998) Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nat Med 4:781-5
15. Ishii K, Amagai M, Hall RP et al. (1997) Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 159:2010-7
16. Ishii K, Amagai M, Komai A et al. (1999) Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 135:943-7
17. Jones RE, Bourdette D, Moes N et al. (2003) Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J Immunol 170:1690-8
18. Kljuic A, Bazzi H, Sundberg JP et al. (2003) Desmoglein 4 in hair follicle differentiation and epidermal adhesion: Evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 113:249-60
19. Koch PJ, Mahoney MG, Ishikawa H et al. (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137:1091-102
20. Kubo A, Amagai M, Hashimoto T et al. (1997) Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3). Br J Dermatol 137:109-13
21. Lehmann PV, Forsthuber T, Miller A et al. (1992) Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-7
22. Li N, Aoki V, Hans-Filho G et al. (2003) The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 197:1501-10
23. Mahoney MG, Wang Z, Rothenberger K et al. (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103:461-8
24. McMahon EJ, Bailey SL, Castenada CV et al. (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11:335-9
25. McRae BL, Vanderlugt CL, Dal Canto MC et al. (1995) Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 182:75-85
26. Miller SD, Vanderlugt CL, Begolka WS et al. (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3:1133-5
27. Müller R, Svoboda V, Wenzel E et al. 2006 IgG reactivity against nonconformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. Exp Dermatol 15 606-14
28. Müller R, Svoboda V, Wenzel E et al. 2008 IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol 17 35-43
29. Nagasaka T, Nishifuji K, Ota T et al. (2004) Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome. J Clin Invest 114:1484-92
30. O'Connor KC, Appel H, Bregoli L et al. (2005) Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol 175:1974-82
31. Ohyama M, Amagai M, Hashimoto T et al. (2001) Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol 44:593-8
32. Olson JK, Croxford JL, Calenoff MA et al. (2001) A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 108:311-8
33. Ota T, Amagai M, Watanabe M et al. (2003) No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases. J Dermatol Sci 32:137-41
34. Robinson WH, Fontoura P, Lee BJ et al. (2003) Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol 21:1033-9
35. Salato VK, Hacker-Foegen MK, Lazarova Z et al. (2005) Role of intramolecular epitope spreading in pemphigus vulgaris. Clin Immunol 116:54-64
36. Seitz CS, Staegemeir E, Amagai M et al. (1999) Pemphigus herpetiformis with an autoimmune response to recombinant desmoglein 1. Br J Dermatol 141:354-5
37. Sekiguchi M, Futei Y, Fujii Y et al. (2001) Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 167:5439-48
38. Stanley JR, Amagai M (2006) Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355:1800-10
39. Steinman L, Conlon P (1997) Viral damage and the breakdown of selftolerance. Nat Med 3:1085-7
40. Tsunoda K, Ota T, Aoki M et al. (2003) Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170:2170-8
41. Tuohy VK, Yu M, Weinstock-Guttman B et al. (1997) Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 99:1682-90
42. Tuohy VK, Yu M, Yin L et al. (1999) Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 189:1033-42
43. Vanderlugt CL, Miller SD (2002) Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2:85-95
44. Whittock NV, Bower C (2003) Genetic evidence for a novel human desmosomal cadherin, desmoglein 4. J Invest Dermatol 120:523-30
45. Zhao ZS, Granucci F, Yeh L et al. (1998) Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection. Science 279:1344-7